For: | Jain L, Kaur J, Ayub S, Ansari D, Ahmed R, Dada AQ, Ahmed S. Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention. World J Psychiatry 2024; 14(6): 760-766 [PMID: 38984339 DOI: 10.5498/wjp.v14.i6.760] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v14/i6/760.htm |
Number | Citing Articles |
1 |
Luz A. Silva-Torres, Ashraf Mozayani. Xylazine abuse, the growing risk: A review of its effects, upsurge use and associated fatalities in the USA and Puerto Rico. Journal of Forensic and Legal Medicine 2024; 108: 102780 doi: 10.1016/j.jflm.2024.102780
|
2 |
Domenico Iacopetta, Alessia Catalano, Francesca Aiello, Inmaculada Andreu, Maria Stefania Sinicropi, Giovanni Lentini. Xylazine, a Drug Adulterant Whose Use Is Spreading in the Human Population from the U.S. to the U.K. and All Europe: An Updated Review. Applied Sciences 2025; 15(6): 3410 doi: 10.3390/app15063410
|
3 |
Thomas L Miller, Jeanette Mathews, George C Dungan, Joseph V Pergolizzi, Robert B Raffa. ENA-001 Reverses Xylazine/Fentanyl Combination-Induced Respiratory Depression in Rats: A Qualitative Pilot Study. Cureus 2024; doi: 10.7759/cureus.74826
|
4 |
Donald E. Greydanus, Ahsan Nazeer, Dilip R. Patel. Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS. Disease-a-Month 2025; 71(3): 101853 doi: 10.1016/j.disamonth.2025.101853
|
5 |
Cory B. Lutgen, Elisabeth Callen, Elise Robertson, Tarin Clay, Gabriela Gaona, Kathryn Cates‐Wessel, Yalda Jabbarpour, Melissa K. Filippi. Assessment of primary care team‐based learning sessions for opioid use disorder. The American Journal on Addictions 2025; doi: 10.1111/ajad.70050
|